Structural basal ganglia disorders
Gene: AP1S2EnsemblGeneIds (GRCh38): ENSG00000182287
EnsemblGeneIds (GRCh37): ENSG00000182287
OMIM: 300629, Gene2Phenotype
AP1S2 is in 14 panels
3 reviews
Arina Puzriakova (Genomics England Curator)
Comment on mode of inheritance: Changed MOI from 'XL, biallelic in females' to 'XL, monoallelic in females'.
Review of literature did not reveal any confirmed affected females. Female carriers of AP1S2 variants are phenotypically normal and have mostly shown random X-inactivation. Huo et al., 2019 (PMID: 30714330) state that they identified a female patient (I-1) but this individual was not available for genetic testing and so it is unclear whether they harboured a variant on a one or both alleles.
As no confirmed female cases have been reported and the allelic requirement remains elusive, the MOI should be set to the default XL (i.e. monoallelic in females may cause disease) as this will ensure that both mono and biallelic variants are picked up in females by the pipeline.Created: 18 Oct 2021, 11:54 a.m. | Last Modified: 18 Oct 2021, 11:54 a.m.
Panel Version: 1.21
Sarah Leigh (Genomics England Curator)
Comment when marking as ready: Associated with phenotype in OMIM and as a confirmed G2P. At least 5 variants reported.Created: 16 Mar 2017, 11:25 a.m.
Comment on publications: 17617514 - identification of AP1S2 variants in a large 4-generation French family, and a Scottish family, marked calcifications of the basal ganglia were reported in affected individuals in both families
18428203 - an additional two families reported "Studying four patients in two unrelated families in which AP1S2 nonsense and splicesite mutations segregated, we found that affected individuals presented, in addition to previously described features, with elevated protein levels in cerebrospinal fluid (CSF). Moreover, computed tomography scans demonstrated that the basal ganglia calcifications associated with AP1S2 mutations appeared during childhood and might be progressive. Based on these observations, we propose that AP1S2 mutations are responsible for a clinically recognizable XLMR and autism syndrome associating hypotonia, delayed walking, speech delay, aggressive behavior, brain calcifications, and elevated CSF protein levels."Created: 16 Mar 2017, 11:23 a.m.
Comment on phenotypes: PETTIGREW SYNDROMECreated: 14 Mar 2017, 6:06 p.m.
Manju Kurian (UCL-Institute of Child Health)
Not that many families with Basal Ganglia changes but probably should include in this panelCreated: 1 Mar 2017, 1:54 p.m.
Mode of inheritance
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)
Details
- Mode of Inheritance
- X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)
- Sources
-
- Expert Review Green
- Emory Genetics Laboratory
- Radboud University Medical Center, Nijmegen
- Phenotypes
-
- Pettigrew syndrome, OMIM:304340
- OMIM
- 300629
- Clinvar variants
- Variants in AP1S2
- Penetrance
- Complete
- Publications
- Panels with this gene
-
- Intracerebral calcification disorders
- Hereditary ataxia
- Fetal anomalies
- Adult onset neurodegenerative disorder
- White matter disorders and cerebral calcification - narrow panel
- Intellectual disability
- Childhood onset dystonia, chorea or related movement disorder
- Structural basal ganglia disorders
- Hereditary ataxia with onset in adulthood
- Hydrocephalus
- Adult onset dystonia, chorea or related movement disorder
- Early onset dystonia
- Ataxia and cerebellar anomalies - narrow panel
- DDG2P
History Filter Activity
Set publications
Arina Puzriakova (Genomics England Curator)Publications for gene: AP1S2 were set to 23756445; 17617514; 18428203
Set mode of inheritance
Arina Puzriakova (Genomics England Curator)Mode of inheritance for gene: AP1S2 was changed from X-LINKED: hemizygous mutation in males, biallelic mutations in females to X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)
Set Phenotypes
Arina Puzriakova (Genomics England Curator)Phenotypes for gene: AP1S2 were changed from Mental retardation, X-linked syndromic 5 304340 to Pettigrew syndrome, OMIM:304340
panel promoted to version 1
Sarah Leigh (Genomics England Curator)promoted 16/03/2017
Gene classified by Genomics England curator
Sarah Leigh (Genomics England Curator)This gene has been classified as Green List (High Evidence).
Set publications
Sarah Leigh (Genomics England Curator)Publications for AP1S2 were set to 23756445; 17617514; 18428203
Set publications
Sarah Leigh (Genomics England Curator)Publications for AP1S2 were set to 23756445; 17617514
Gene classified by Genomics England curator
Sarah Leigh (Genomics England Curator)This gene has been classified as Green List (High Evidence).
Set Phenotypes
Sarah Leigh (Genomics England Curator)Phenotypes for AP1S2 were set to Mental retardation, X-linked syndromic 5 304340
Set publications
Sarah Leigh (Genomics England Curator)Publications for AP1S2 were set to 23756445; 17617514
Added New Source
Sarah Leigh (Genomics England Curator)AP1S2 was added to Structural basal ganglia disorderspanel. Source: Emory Genetics Laboratory
Added New Source
Sarah Leigh (Genomics England Curator)AP1S2 was added to Structural basal ganglia disorderspanel. Sources: Radboud University Medical Center, Nijmegen
Created
Sarah Leigh (Genomics England Curator)AP1S2 was created by sleigh